Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F B Hollinger

Showing results (131-140 of 157) with videos related to

Pageof 16
Sort By:
The American Journal of Gastroenterology|January 1, 1994
Non-A, non-B fulminant hepatitis is also non-E and non-CS K Kuwada, V M Patel, F B Hollinger, et al.
The Journal of Infectious Diseases|March 1, 1997
Defining the time of fetal or perinatal acquisition of human immunodeficiency virus type 1 infection on the basis of age at first positive culture. Women and Infants Transmission Study (WITS)L A Kalish, J Pitt, J Lew, et al.
Nature|January 14, 1982
Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptidesG R Dreesman, Y Sanchez, I Ionescu-Matiu, et al.
Blood|January 15, 1993
A multicenter study of viral hepatitis in a United States hemophilic populationC L Troisi, F B Hollinger, W K Hoots, et al.
Journal of Virology|May 1, 1983
Inhibition of a common human anti-hepatitis B surface antigen idiotype by a cyclic synthetic peptideR C Kennedy, G R Dreesman, J T Sparrow, et al.
The Journal of Infectious Diseases|April 1, 1994
Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. Aids Clinical Trials Group Virology LaboratoriesV DeGruttola, L A Beckett, R W Coombs, et al.
Transfusion|January 1, 1995
Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipientsJ W Mosley, C E Stevens, R D Aach, et al.
HIV Medicine|October 20, 2007
Impact of GB virus type C infection on mother-to-child HIV transmission in the Women and Infants Transmission Study CohortE Handelsman, I Cheng, B Thompson, et al.
Acta Haematologica Polonica|July 1, 1980
Post-transfusion hepatitis: analysis of risk factorsR D Aach, F B Hollinger, W Szmuness, et al.
AIDS (London, England)|January 1, 1990
A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative GroupR B Roberts, F B Hollinger, W P Parks, et al.
Pageof 16

Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
The American Journal of Gastroenterology|January 1, 1994
Non-A, non-B fulminant hepatitis is also non-E and non-CS K Kuwada, V M Patel, F B Hollinger, et al.
The Journal of Infectious Diseases|March 1, 1997
Defining the time of fetal or perinatal acquisition of human immunodeficiency virus type 1 infection on the basis of age at first positive culture. Women and Infants Transmission Study (WITS)L A Kalish, J Pitt, J Lew, et al.
Nature|January 14, 1982
Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptidesG R Dreesman, Y Sanchez, I Ionescu-Matiu, et al.
Blood|January 15, 1993
A multicenter study of viral hepatitis in a United States hemophilic populationC L Troisi, F B Hollinger, W K Hoots, et al.
Journal of Virology|May 1, 1983
Inhibition of a common human anti-hepatitis B surface antigen idiotype by a cyclic synthetic peptideR C Kennedy, G R Dreesman, J T Sparrow, et al.
The Journal of Infectious Diseases|April 1, 1994
Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. Aids Clinical Trials Group Virology LaboratoriesV DeGruttola, L A Beckett, R W Coombs, et al.
Transfusion|January 1, 1995
Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipientsJ W Mosley, C E Stevens, R D Aach, et al.
HIV Medicine|October 20, 2007
Impact of GB virus type C infection on mother-to-child HIV transmission in the Women and Infants Transmission Study CohortE Handelsman, I Cheng, B Thompson, et al.
Acta Haematologica Polonica|July 1, 1980
Post-transfusion hepatitis: analysis of risk factorsR D Aach, F B Hollinger, W Szmuness, et al.
AIDS (London, England)|January 1, 1990
A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative GroupR B Roberts, F B Hollinger, W P Parks, et al.
Pageof 16